---
title: "MultiPlan (MPLN) Expected to Announce Quarterly Earnings on Tuesday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238457828.md"
description: "MultiPlan (NYSE:MPLN) is set to announce its Q1 2025 earnings on May 6, with analysts predicting a loss of $2.14 per share. The stock recently traded at $22.41, down $0.58, with a market cap of $362.39 million. Citigroup has raised its price target for MultiPlan from $10.00 to $12.50, maintaining a \"neutral\" rating. The company specializes in data analytics and cost management solutions for the healthcare sector in the U.S."
datetime: "2025-05-01T14:19:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238457828.md)
  - [en](https://longbridge.com/en/news/238457828.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238457828.md)
---

# MultiPlan (MPLN) Expected to Announce Quarterly Earnings on Tuesday

MultiPlan (NYSE:MPLN - Get Free Report) is expected to be posting its Q1 2025 quarterly earnings results before the market opens on Tuesday, May 6th. Analysts expect MultiPlan to post earnings of ($2.14) per share for the quarter.

## MultiPlan Stock Performance

MPLN stock traded down $0.58 during trading on Tuesday, hitting $22.41. The company had a trading volume of 45,170 shares, compared to its average volume of 114,228. MultiPlan has a 1-year low of $4.80 and a 1-year high of $31.01. The firm has a 50-day moving average price of $20.99 and a 200-day moving average price of $15.48. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 21.73. The firm has a market cap of $362.39 million, a PE ratio of -0.24 and a beta of 0.13.

## Analyst Upgrades and Downgrades

Separately, Citigroup lifted their price objective on MultiPlan from $10.00 to $12.50 and gave the stock a "neutral" rating in a research report on Friday, January 10th.

**Check Out Our Latest Research Report on MPLN**

## About MultiPlan

(Get Free Report)

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.

## Featured Stories

-   Five stocks we like better than MultiPlan
-   5 Top Rated Dividend Stocks to Consider
-   These 3 Cybersecurity Stocks Are Defying the Downturn
-   Which Wall Street Analysts are the Most Accurate?
-   T-Mobile US: The Un-Carrier Is an Indisputable Buy on the Dip
-   Learn Technical Analysis Skills to Master the Stock Market
-   3M Stock: 4 Compelling Reasons to Buy, 1 Big Reason to Pass

_This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com._

## Should You Invest $1,000 in MultiPlan Right Now?

Before you consider MultiPlan, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list.

While MultiPlan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

### Related Stocks

- [MPLN.US](https://longbridge.com/en/quote/MPLN.US.md)